diet-related metabolism dysfunction Prevention of cardiovascular diseases
Conditions
Interventions
Group 1: children aged 3 - 5.
Measurements:
Anamnesis and clinical examinations,
bioimpedance analysis,
body composition analysis,
energy metabolism,
genotyping via salvia,
metabolomics via urine,
Sponsors
Lehrstuhl für Ernährungsmedizin der Technischen Universität München
Eligibility
Sex/Gender
All
Age
3 Years to 85 Years
Inclusion criteria
Inclusion criteria: • Children aged 3-5, coorparativeness of children and parents, normal weight, girls/boys, caucasian. • Adolescents aged 18 - 25, coorparativeness, BMI 18-35 kg/m2, women/men, caucasian. • Adults aged 40-65, coorparativeness, BMI 18-35 kg/m2, women/men, caucasian. • Elderly aged 75-85, coorparativeness, no guardianship, women/men, iliving in private household, mobile, caucasian.
Exclusion criteria
Exclusion criteria: Children aged 3-5: missing cooperativeness of parents, current participation in an intervention study, chronic disease (allergic asthma), other metabolic and autoimmune diseases, genetic syndrome (e.g. Prader-Willi, Trisomie 21), blood transfusion in the last 2 month. Adolescents aged 18-25 and Adults aged 40-65: missing cooperativeness, current participation in an intervention study, smoker, pregnancy, chronic disease, diabetes, metabolic- and autoimmune disease, untreatet endocrine disease, myocardial infarction within the last 3 years, stroke within the last 3 years, pacemaker, untreatet hypertension >160/95 mmHg, coronary cardiopathy within the last 3 years, cancer within the last 3 years, kidney disease requiring dialysis, Parkinson disease, liver disease, stomach ulcer, chronic lung disease with oxygen supply, circulatory disorder, mental illness or neuroleptic desease, immobile (chairbound), unintentionally loss in weight in the last 3 month, blood transfusion in the last 3 month Elderly aged 75-85: missing cooperativeness, current participation in an intervention study, smoker, chronic disease, diabetes, metabolic- and autoimmune disease, untreatet endocrine disease, myocardial infarction within the last 3 years, stroke within the last 3 years, pacemaker, untreatet hypertension >150/95 mmHg, coronary cardiopathy within the last 3 years, cancer within the last 3 years, kidney disease requiring dialysis, Parkinson disease, liver disease, stomach ulcer, chronic lung disease with oxygen supply, circulatory disorder mental illness or neuroleptic desease, immobile (chairbound), nursing case, unintentionally loss in weight >5% in the last 3 month, blood transfusion in the last 3 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Phenotyping | — |
Countries
Germany
Contacts
Public ContactRachel Rennekamp
Else Kröner-Fresenius-Zentrum für Ernährungsmedizin der TU München
Outcome results
None listed